Cipla Sees Growth In Product-Based Alliances; In Deal With Teva For Inhalers In Russia
This article was originally published in PharmAsia News
Executive Summary
India’s second largest drug maker draws newer strategies to keep pace with emerging markets’ growth momentum, Cipla Chairman Yusuf Hamied tells PharmAsia News in an exclusive interview.